Benchmark’s partners are making a case for resisting the venture market’s tempo without retreating from its opportunities. In their latest interview, they described an approach built around sustained relationships, selective investments and a continuing attachment to San Francisco. The argument is not that technological change can wait. It is that investors may respond better through close collaboration than through a faster succession of transactions. Their expanding resources, however, introduce a question: how much can the firm change financially while preserving its working methods?

This summer, Benchmark announced $2 billion across two funds, only the second departure from a much smaller fundraising vehicle in its 31-year history. Its five partners nevertheless described an unchanged investment rhythm of two or three new investments per partner each year. The new growth fund accounts for $1. Peter Fenton said the core fund had remained at $500 million for 20 years before its enlargement. These figures describe a firm increasing its financial reach while the partners’ account suggests that their attention remains a constraint on expansion.

Fenton’s defence of that distinction starts with duration. Working with founders from an early stage generally means a 10-to-15-year relationship, he said, and that involvement cannot simply expand alongside fund size. He characterised the larger core fund as an adjustment for inflation, rather than a change in investment practice. His argument for growth investing was different: the early-stage restriction had excluded opportunities that, in his assessment, would have returned between 10 and 1,000 times Benchmark’s investment. Those are retrospective assessments of missed opportunities, not realised results, but they explain the pressure to broaden the mandate.

Read more: Tesla shareholders and the unanswered questions over a potential SpaceX merger

Concentration is the proposed bridge between greater resources and limited partner capacity. Fenton suggested the growth fund might make four to six investments, or perhaps seven to eight, while acknowledging that partners had different answers. He envisaged one or two investments producing 90% of returns if the fund succeeds. This is a statement of investment philosophy, not a forecast supported by disclosed portfolio outcomes. Its strength is that substantial capital need not require a high transaction count. Its corresponding vulnerability is that success becomes heavily dependent on a small number of decisions.

The partnership’s organisation reflects the same preference. Ev Randall contrasted small partnerships with firms employing 50- or 60-person investment teams and dividing decisions among specialised groups. He favours the more direct exchanges possible within a smaller team. Jack Altman similarly argued that formal voting and elaborate systems would make more sense if Benchmark invested in 100 or 200 companies annually. Chethan Puttagunta said unstructured Monday discussions leave room to help founders with executive recruitment or strategic partnerships. The strongest case for informality is therefore practical responsiveness, rather than an objection to process in every setting.

That case also has limits. Asked whether one partner could block an investment, the partners did not identify a settled rule. For a low-volume partnership, shared judgement may substitute for procedural clarity; whether that remains sufficient as the mandate broadens is an open question. Benchmark’s San Francisco commitment complements its emphasis on a closely connected team, but the interview does not establish that local roots themselves generate superior returns. The evidence supports a description of how these partners prefer to work, not a universal prescription for where venture investors should operate.

Read more: Flight disruptions leave thousands of Indian Muslim pilgrims stranded in Saudi Arabia

Cerebras illustrates why patience need not mean avoiding unfamiliar businesses. Eric Vishria said Benchmark invested in its first round in the spring of 2016, despite having made no hardware investment in 10 years. Vishria recalled Fenton saying that the proposal went against everything he had learned in venture investing; Fenton defended the founders’ willingness to pursue an unconventional idea. Cerebras priced its flotation earlier in 2026 at $185 per share, rose to $350 and returned near $185. That sequence neither validates nor disproves Benchmark’s original judgement. It does show why a long investment horizon and public-market price movements answer different questions.

The clearest competing arguments concern how companies should reach those public markets. Former Benchmark partner Bill Gurley has advocated direct listings, arguing that the conventional flotation’s initial price jump rewards bankers and their clients rather than the issuing company. Vishria accepted that direct listings can be appropriate but argued that capital-hungry AI businesses face a different imperative. Cerebras raised $6 billion through its flotation, he said. Gurley’s concern is about who captures value in the transaction; Vishria’s is about securing financing. Neither consideration eliminates the other, and the company’s funding needs matter to the choice.

Randall also disputed the interpretation of Character.AI’s Chapter 11 filing as evidence of a broader AI downturn. He pointed to its founder and team joining Google a year and a half earlier and described the business as already sold for $2.3 billion. His contention was that discussion on X had stripped away that context. This is a narrower argument than a demonstration that the market is sound: a single bankruptcy cannot by itself establish a general collapse, but explaining it does not settle the wider concerns about financing and cash consumption raised in the interview.

What follows will test the compatibility of Benchmark’s commitments rather than resolve an argument between speed and caution in the abstract. More capital can help the firm support founders beyond its earlier remit; concentration can preserve attention while magnifying dependence on individual outcomes. Puttagunta acknowledged that Benchmark will not back every successful company. That acceptance is central to its patient approach. The unanswered question is whether the enlarged funds can maintain the same selectivity and depth of involvement—and whether the eventual results justify the opportunities deliberately left to others.